Lv1
10 积分 2023-12-31 加入
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
22小时前
已完结
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
2天前
已完结
Metal vacancies in semiconductor oxides enhance hole mobility for efficient photoelectrochemical water splitting
15天前
已完结
Andrographolide Inhibits Lipotoxicity-Induced Activation of the NLRP3 Inflammasome in Bone Marrow-Derived Macrophages
1个月前
已完结
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice
2个月前
已完结
Asiaticoside, a component of Centella asiatica attenuates RANKL‐induced osteoclastogenesis via NFATc1 and NF‐κB signaling pathways
2个月前
已完结
Key metalloproteinase-mediated pathways in the kidney
3个月前
已完结
Advancements in Diabetic Kidney Disease Management: Integrating Innovative Therapies and Targeted Drug Development
4个月前
已完结
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
11个月前
已完结
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
11个月前
已完结
皖公网安备34019202002308
